Browse Items (113 total)
Sort by:
The Shaping of US Biodefense Posture
This report is an historical analysis of US biodefense and bioweapons posture in order to understand the disparity between chemical weapons preparedness and biological weapons preparedness.
Risk and Benefit Analysis of Gain of Function Research: Final Report
Conducted risk analyses or accidents, natural disasters, biosecurity, and a benefit assessment. Focuses on influenza viruses and coronaviruses.
H5N1: A Case Study for Dual Use Research
The author uses the threat of a global pandemic caused by H5N1 to advocate for dual use research and make recommendations to improve it.
Medical Management of Biological Casualties Handbook
The purpose of this handbook is to serve as a concise, pocket-sized manual that can be used in a crisis to guide medical personnel in the prophylaxis and management of biological casualties.
Proposed Framework for the Oversight of Dual-use Life Sciences Research: Strategies for Minimizing the Potential Misuse of Research Information
Discusses considerations for institutional evaluation of the dual-use risk of proposed research.
Stewardship or Censorship: Balancing Biosecurity, the Public's Health, and the Benefits of Scientific Openness
This document discusses the conflict between open scientific communication and national security in the biosciences in order to contribute to the national dialogue on the costs and benefits of regulatory regimes.
Twenty-First Century Biological Threats
This hearing before the Subcommittee on Bioterrorism and Public Health Preparedness aims to assess current biological threats in order to decide the necessary countermeasures to be developed.
Biodefense: Next Steps
This hearing before the Subcommittee on Bioterrorism and Public Health Preparedness discusses the threat to US security posed by bioterrorism.
Small-Scale Terrorist Attacks Using Chemical and Biological Agents: An Assessment Framework and Preliminary Comparisons
This report assesses the threat posed by small-scale terrorist attacks using biological, chemical, and toxin agents rather than traditional risk assessments which focus on mass casualty attacks.
NIAID Research Agenda for CDC Category A Agents
This progress report details the progress of the National Institute of Allergy and Infectious Diseases towards the recommendations made by the Blue Ribbon Panel on Bioterrorism and Its Implications for Biomedical Research in February 2002. These…
Public Health Assessment of Potential Biological Terrorism Agents
Presented risk ranking system that broke agents into three tiers: A, B, and C.
Foot and Mouth Disease: To Protect U.S Livestock, USDA Must Remain Vigilant and Resolve Outstanding Issues
This report discusses the dangers to livestock of foot and mouth disease and whether or not we can prevent it in the US following an outbreak in the UK.
Bioterrorism, 2001
In the wake of the 9/11 terrorist attacks, the Subcommittee of the Committee on Appropriations discusses US preparedness for a bioterrorism event in a series of hearings over a few weeks.
Working Paper Submitted by Argentina
This paper classifies biological agents contained on the BWC weapons agent lists.
Bioterrorism: Our Frontline Response, Evaluating US Public Health and Medical Readiness
This hearing before the Subcommittee on Public Health examines topics related to US bioterrorism preparedness, such as the national pharmaceutical stockpile, deterrence, outbreak containment, and research and development.